about
Angiopoietin-2 in white adipose tissue improves metabolic homeostasis through enhanced angiogenesisAdiponectin is an endogenous anti-fibrotic mediator and therapeutic target.Tenomodulin promotes human adipocyte differentiation and beneficial visceral adipose tissue expansion.microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolismFasting selectively blocks development of acute lymphoblastic leukemia via leptin-receptor upregulation.General theory of skin reinforcement.An adipo-biliary-uridine axis that regulates energy homeostasis.Adipocyte-myofibroblast transition as a possible pathophysiological step in androgenetic alopecia.Differential glucose requirement in skin homeostasis and injury identifies a therapeutic target for psoriasis.PPARγ and its Role in Adipocyte Homeostasis and Thiazolidinedione-Mediated Insulin Sensitization.Glucose-regulated protein 78 is essential for cardiac myocyte survival.Caveolin-1 as a pathophysiological factor and target in psoriasisCaveolin-1 as a target in prevention and treatment of hypertrophic scarringLipotoxicity and Cell Maintenance in Obesity and Type 2 DiabetesAdiponectin modulates ventral tegmental area dopamine neuron activity and anxiety-related behavior through AdipoR1.Cellular Origins of Beige Fat Cells RevisitedAdipogenesis and metabolic healthImaging Metabolically Active Fat: A Literature Review and Mechanistic InsightsCaveolin-1 as a possible target in the treatment for acneLeptin: Less Is MoreA Novel Model of Diabetic Complications: Adipocyte Mitochondrial Dysfunction Triggers Massive β-Cell HyperplasiaInduction of Effective Immunity against Trypanosoma cruziBeyond adiponectin and leptin: adipose tissue-derived mediators of inter-organ communicationCritical Role of Matrix Metalloproteinase 14 in Adipose Tissue Remodeling during ObesityThe many secret lives of adipocytes: implications for diabetesTissue-specific disruption of Kbtbd2 uncovers adipocyte-intrinsic and -extrinsic features of the teeny lipodystrophy syndrome
P50
Q33563447-4CD53482-B04C-4F2E-93F2-C45705AA001CQ33860888-067019E7-4457-420C-A5C4-1E11A63F07A0Q36591198-79C049D1-5BBB-4AA3-8187-9EB09DF6C41AQ37651950-617DC70B-2103-4D51-8B47-1F1C3AB8C216Q38726681-4448D6D0-608B-4959-A9A4-6118F56CD6A7Q41348979-E618CB10-AF37-41F1-9F9A-07A65E852043Q48044766-5F7478E8-BBA0-47AA-9E70-EDDE529873E3Q48176413-ECBC443A-2DB1-4FAA-8D74-65D74DE57DFFQ52584555-1ABDB9AD-9096-462E-ACAD-21EF1AB62981Q52684405-ED12BD9F-FEFC-4A5F-9031-7D31669163E2Q52718679-5ADB6848-D633-484E-8DA0-DC158256D2F4Q61799415-CF52463D-276F-487C-AC2A-C05FF3A4A9B0Q64086326-85587EA7-8501-410D-BFD6-3A68D6729175Q64230296-1B8B77AD-A440-4AF1-8866-AF33AEB85E42Q64982758-2E5E4327-C555-4B2F-8740-D58B40385B5EQ90196430-DFF68EEC-8B46-4A7B-89FE-A9F3DDC11501Q90893796-4872E0D7-A5ED-4A35-A30A-9F6689414B6EQ91147333-495BDF0B-23CB-4DFC-A39C-415295C3BC96Q91460349-1682033F-A119-48AA-BF2C-F07684CB239FQ92092189-3926741F-B7BC-4D9F-8749-80571FFBE964Q92287079-67B11BD9-4BB4-44CF-AA70-B86CA1EA37FDQ92452308-6EE4FFC9-B589-4623-AC42-DC237F96C720Q92825077-2EE065F6-B8E6-4E11-B09D-16161C0D7230Q92976697-C9F59DFB-707E-4706-B0AB-CCD1489424E0Q93345358-57FDDD88-0BA1-4081-8F70-616DF80F7C34Q94548832-88424F05-ED43-41AE-BE93-E82A1426C67F
P50
description
researcher
@en
name
Philipp E Scherer
@en
type
label
Philipp E Scherer
@en
prefLabel
Philipp E Scherer
@en
P31
P496
0000-0003-0680-3392